Pathogenicity of the LDLR c. 97C> T (p. Gln33Ter ) Mutation in Familial Hypercholesterolemia
Molecular Genetics & Genomic Medicine · 2024
DOI: 10.1002/mgg3.70030 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Kaihan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Receptors, LDL, Hyperlipoproteinemia Type II, Pedigree, Codon, Nonsense. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Key Technology R&D Program of Ningbo, Medical and Health Research Project of Zhejiang Province.
Abstract (Originalsprache)
Background
Familial hypercholesterolemia (FH) is a hereditary disease caused mainly by mutations in the gene encoding the low‐density lipoprotein receptor (LDLR). This study aimed to confirm the pathogenicity of the LDLR c.97C>T (p.Gln33Ter) mutation through in vitro functional validation and determine whether this nonsense mutation induces nonsense‐mediated mRNA decay (NMD).
Methods
The proband and his family were included in accordance with Chinese Expert Consensus on FH screening. The disease‐causing mutations were fund using whole‐exome sequencing and were confirmed using bidirectional Sanger sequencing. The pathogenicity of the mutation was predicted using in silico analysis. The LDLR c.97C>T (p.Gln33Ter) mutation was generated using site‐directed mutagenesis and expressed in HEK293T cells lacking endogenous LDLR expression. The effects of this alteration on LDLR expression and LDL uptake were assessed using flow cytometry, quantitative polymerase chain analysis, western blotting, and confocal laser scanning microscopy.
Results
The mutation that causes FH in this family was LDLR c.97C>T (p.Gln33Ter), and family members with this mutation exhibited elevated levels of low‐density lipoprotein cholesterol (LDL‐C). The cell experiment results showed that this mutation prevented the synthesis of LDLR protein and caused the cells to lose their LDL uptake ability.
Conclusion
LDLR c.97C>T (p.Gln33Ter) is a pathogenic FH mutation. However, this nonsense mutation did not induce NMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
- Department of Noninvasive Electrocardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
- Department of Cardiology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quezhou, Zhejiang, China.
ORCID-Profile: Kaihan Wang
Förderung
- the Key Technology R&D Program of Ningbo
- Medical and Health Research Project of Zhejiang Province
Zitieren
APA
Wang, K., Hu, T., Tai, M., Shen, Y., Lin, S., Guo, Y., & Chen, X. (2024). Pathogenicity of the LDLR c. 97C> T (p. Gln33Ter ) Mutation in Familial Hypercholesterolemia. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70030
Vancouver
Wang K, Hu T, Tai M, Shen Y, Lin S, Guo Y, et al. Pathogenicity of the LDLR c. 97C> T (p. Gln33Ter ) Mutation in Familial Hypercholesterolemia. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.70030
BibTeX
@article{Wang2024,
author = {Wang, Kaihan and Hu, Tingting and Tai, Mengmeng and Shen, Yan and Lin, Shaoyi and Guo, Yongjuan and Chen, Xiaomin},
title = {Pathogenicity of the LDLR c. 97C> T (p. Gln33Ter ) Mutation in Familial Hypercholesterolemia},
journal = {Molecular Genetics & Genomic Medicine},
year = {2024},
doi = {10.1002/mgg3.70030}
}
EUVIMED